Related by context. All words. (Click for frequent words.) 71 postprandial glucose 71 plasma glucose levels 69 serum urate 69 blood glucose concentrations 69 plasma glucose 68 glycosylated hemoglobin HbA1c 68 hemoglobin A1c HbA1c 68 lispro 67 glycosylated hemoglobin levels 67 triacylglycerol concentrations 67 nocturnal hypoglycaemia 67 plasma triglycerides 67 triglyceride concentrations 67 fructosamine 67 #.#mmHg 66 post prandial glucose 66 NPH insulin 66 postprandial insulin 65 glycemia 65 Hb A1C 65 insulin detemir 65 Fasting plasma glucose 65 LDL triglycerides 65 iPTH 65 #mg/day [001] 65 detemir 64 NovoMix ® 64 serum uric acid 64 serum glucose 64 nonfasting 64 fasting plasma glucose FPG 64 glycated hemoglobin levels 64 postprandial glucose levels 64 blood lipid profiles 64 glucose concentrations 64 alanine aminotransferase ALT 64 serum cortisol 63 ghrelin concentrations 63 HbA1C levels 63 serum concentrations 63 serum triglycerides 63 serum LDL cholesterol 63 fasting glucose levels 63 serum urate levels 63 fasting plasma glucose 63 hemoglobin A1c levels 63 serum lipid 63 Fasting glucose 63 aspartate aminotransferase AST 63 serum triglyceride levels 63 serum insulin 63 urine albumin 63 serum homocysteine 62 Apidra ® 62 fasting triglycerides 62 HbA1C 62 fasting blood glucose 62 serum potassium 62 colorectal adenoma 62 HbA 1c levels 62 salivary cortisol 62 peak VO2 62 serum phosphate 62 timepoints 62 postprandial glucose PPG 62 Fasting blood glucose 62 pharmacokinetic PK profile 62 transaminase levels 62 elevated creatinine 62 stimulates insulin secretion 61 APIDRA R 61 alanine aminotransferase 61 blood Phe levels 61 glomerular filtration 61 glycaemia 61 #.#mmol L [002] 61 lispro alone 61 #mmHg [001] 61 plasma leptin 61 #mg/day [002] 61 serum sodium levels 61 nicardipine 61 insulin lispro 61 serum lipid levels 61 μg kg 61 tertiles 61 QTcF 61 AST ALT 61 lowering blood glucose 61 insulin glulisine 61 dosing frequency 61 oral antidiabetic medication 61 serum phosphate levels 61 diastolic BP 61 A1c levels 61 N telopeptide 61 urinary albumin excretion 61 NovoLog ® Mix 61 hemoglobin concentrations 61 homocysteine concentrations 61 triacylglycerol 61 serum cholesterol 61 glulisine 61 serum magnesium 61 OGTT 60 biphasic insulin aspart 60 postprandial glycemia 60 VLDL cholesterol 60 serum CRP 60 Triglyceride levels 60 atazanavir ritonavir 60 HbA1c levels 60 isocaloric 60 PASI scores 60 acromegalic patients 60 glycated hemoglobin HbA1c 60 elevated uric acid 60 Calorie intake 60 inhaled iloprost 60 metformin sulphonylurea 60 albumin excretion 60 HbA 1c 60 HOMA IR 60 PSA nadir 60 systolic blood pressures 60 baseline HbA1c 60 elevated LDL cholesterol 60 plasma lipid 60 creatinine levels 60 urinary albumin 60 lowers blood glucose 60 attain statistical significance 60 EDARBI 60 eNO 60 mmHg diastolic 60 neutrophil counts 60 overt nephropathy 60 IOP lowering 60 undetectable viral 60 sUA levels 60 + PH# 60 μmol L 60 mean serum phosphorus 60 exogenous insulin 60 #OHD levels 60 deferasirox 60 nonfasting triglyceride levels 60 demonstrated clinically meaningful 60 LANTUS R 59 albumin excretion rate 59 apnea hypopnea 59 intermittent dosing 59 fasting triglyceride levels 59 fasting insulin 59 #mg/dL [001] 59 Cmax 59 dose clopidogrel 59 transaminases 59 plasma urate 59 apolipoprotein B 59 LDL cholesterol concentrations 59 μg liter 59 alanine transaminase 59 SGPT 59 total cholesterol triglycerides 59 sitosterol 59 glycated hemoglobin 59 osmolality 59 systolic BP 59 salmeterol fluticasone 59 c reactive protein 59 postprandial 59 urinary N telopeptide 59 insulin aspart 59 oxidized LDL cholesterol 59 Creatinine 59 serum phosphorus 59 lipid parameters 59 serum bicarbonate 59 6mg 59 hyperphenylalaninemia HPA due 59 serum ALT 59 #.#/#.# mmHg [001] 59 CK MB 59 creatine phosphokinase 59 prospectively stratified 59 liver transaminases 59 severe exacerbations 59 serum IGF 59 lowest tertile 59 leukocyte count 59 fluticasone salmeterol 59 Carbohydrate intake 59 serum HBV DNA 59 atorvastatin #mg 59 artery clogging LDL cholesterol 58 salivary flow 58 FOSRENOL ® 58 irbesartan 58 hemoglobin A1C 58 CPAP adherence 58 LDL cholesterol HDL cholesterol 58 -#.# mg dL [002] 58 bolus insulin 58 pulmonary capillary wedge 58 creatinine ratio 58 serum calcium levels 58 plasma renin 58 posttreatment 58 carbohydrate oxidation 58 systolic diastolic 58 Lipitor #mg 58 hyperglycaemia 58 plasma cortisol 58 prandial 58 dietary carbohydrate 58 β blockers 58 triacylglycerols 58 plasma lipids 58 daily subcutaneous injections 58 SpO 2 58 serum aminotransferase levels 58 lactate dehydrogenase LDH 58 intact parathyroid hormone 58 triglyceride lowering 58 aminotransferases 58 serum creatinine levels 58 dose titration 58 μg d 58 potassium supplementation 58 #/#mmHg 58 hematological parameters 58 triglyceride concentration 58 serum PTH 58 LDL HDL ratio 58 CI -#.# 58 #mm Hg 58 highest tertile 58 #μg [001] 58 Secondary endpoints included 58 paricalcitol 58 fasting plasma 58 cardiac autonomic 58 nonfasting triglycerides 58 SGOT 58 atherogenic dyslipidemia 58 #mg/dL [002] 58 serum parathyroid hormone 58 insulin degludec 58 serum phosphorus levels 58 brachial artery flow 58 creatine kinase 58 serum lipids 58 glycemic variability 58 Insulin PH# 58 bolus dosing 58 hsCRP levels 58 glucose insulin 58 #.#mg/dL 58 mmol l 58 elevated fasting glucose 58 concentration Cmax 58 probiotic supplementation 58 systemic hypotension 58 serum retinol 58 HBeAg seroconversion 58 glycosylated hemoglobin 58 acetazolamide 58 plasma HCV RNA 58 exhaled NO 58 serum TSH 58 PSADT 58 sodium excretion 58 lipid profiles 58 mm Hg systolic 58 mealtime glucose 58 muscle protein synthesis 58 thiazide diuretics 58 serum ferritin 58 platelet reactivity 58 Apidra R 58 nondiabetic patients 58 flow mediated dilation 58 magnesium intake 58 platelet stickiness 57 endogenous glucose 57 severe hypoglycaemia 57 fat oxidation 57 Serum creatinine 57 glycemic index foods 57 antioxidant intake 57 hematologic parameters 57 antidiabetic medications 57 BENICAR HCT 57 moderate renal impairment 57 9mg 57 viral titers 57 blood Phe 57 dalteparin 57 plasma folate 57 uM 57 relapsed MM 57 clinically meaningful reductions 57 blood glucose levels 57 serum phosphorous 57 isoflavone intake 57 aspirin clopidogrel 57 aplindore 57 desvenlafaxine succinate 57 HBV DNA levels 57 LDL HDL 57 urinary excretion 57 lipid levels 57 VIAject 57 sUA 57 HDL triglycerides 57 postintervention 57 urinary citrate 57 mcg ml 57 aspartate aminotransferase 57 serum triglyceride 57 albuminuria 57 HDL LDL 57 elevated prolactin 57 peptide YY 57 corticosteroid dose 57 certolizumab 57 blood lactate 57 urinary oxalate 57 inflammatory biomarkers 57 elevated blood glucose 57 plasma glucose concentrations 57 leukocyte counts 57 Glomerular filtration rate 57 oral hypoglycemic agents 57 anti Xa 57 aPTT 57 gastric acidity 57 Elevated serum 57 HER2 expression 57 improves insulin sensitivity 57 triglyceride TG 57 #.#g/day 57 K DOQI 57 plasma concentrations 57 Hypoglycaemia 57 Secondary endpoints include 57 tissue oxygenation 57 statin monotherapy 57 sulfonylurea metformin 57 artery stenosis 57 tHcy 57 maximal dose 57 nmol l 57 hemoglobin A1C HbA1C 57 zonisamide SR 57 endothelium dependent 57 cholesterols 57 racemic albuterol 57 pulmonary arterial 57 locomotor activity 57 cholesterol LDL C 57 insulin glargine 57 intravenous dosing 57 periprocedural 56 adiponectin levels 56 International Normalized Ratio 56 mealtime insulin 56 leucopenia 56 milli grams 56 systemic corticosteroid 56 improves glycemic 56 retinal thickness 56 lactate dehydrogenase 56 dose atorvastatin 56 hepatic enzymes 56 acarbose 56 regulates blood glucose 56 postoperative AF 56 Vitamins minerals 56 malondialdehyde MDA 56 4mg/kg 56 endothelial activation 56 Viral load 56 plasma homocysteine 56 vitamin D3 cholecalciferol 56 serum calcium 56 SCr 56 lipoprotein levels 56 dietary nitrate 56 HbA 1C 56 8 OHdG 56 Tasigna prolongs 56 ULORIC 56 carbohydrate absorption 56 SERCA2a 56 RBP4 levels 56 serum vitamin D 56 hour bronchodilation 56 TC HDL 56 bronchodilation 56 tapentadol ER 56 HDL cholesterol triglycerides 56 pyridostigmine 56 hepatic insulin sensitivity 56 normotensive 56 adenoma recurrence 56 bilirubin liver 56 angiotensin II receptor blockers 56 Hemoglobin A1c 56 hepatic enzyme 56 subcutaneous insulin 56 fasting hyperglycemia 56 pharmacokinetic parameters 56 thyroid stimulating hormone 56 liver histology 56 coadministration 56 bronchial hyperresponsiveness 56 Caloric intake 56 primary hypercholesterolemia 56 hepatic fat 56 metabolic parameters 56 #mmHg [002] 56 oral anticoagulation 56 maximal oxygen 56 intracerebral haemorrhage 56 eosinophil count 56 glargine 56 abacavir lamivudine 56 oral prednisolone 56 antiangiogenic therapy 56 creatinine clearance 56 ispinesib administered 56 A1C levels 56 Lantus ® 56 lowering systolic blood 56 urine excretion 56 Primary endpoints 56 mg/m2 dose 56 antihypertensive medication 56 Calcium intake 56 oral hypoglycemics 56 Crohn Disease Activity 56 ml min 56 hemoglobin hematocrit 56 #mg/dl 56 anagrelide 56 vasodilatation 56 PRADAXA #mg 56 CYP#D# inhibitor 56 glomerular filtration rate 56 Alanine 56 flavanol cocoa 56 metformin sulfonylurea 56 tirofiban 56 transaminase elevations 56 hemoglobin concentration 56 inversely associated 56 Plasma concentrations 56 cholesterol esters 56 postoperative mortality 56 hMG 56 plasma homocysteine levels 56 antihypertensive therapy 56 umol L 56 adiponectin concentrations 56 cortisol concentrations 56 IgG antibody 56 min -1 56 virologic suppression 56 sitagliptin 56 peak plasma concentrations 56 Lipoic acid 56 euthyroid 56 maximally tolerated 56 Insulin sensitivity 56 hypocaloric diet 56 tryptase 56 extrapyramidal symptoms 56 ADCS ADL 56 6MWD 56 atherogenic lipids 56 premixed insulin 56 inorganic nitrate 56 Unsaturated fats 56 olmesartan 56 NIASPAN 56 pioglitazone HCl 56 oxidative stress markers 55 mmol 55 3mg 55 dietary sodium 55 specific IgE 55 KDOQI 55 bronchodilatory 55 elevated LDH 55 L glutamine 55 Intraocular pressure 55 CK # plasma concentrations 55 mL/min/#.# m 2 55 cholestrol 55 basal bolus therapy 55 mmol liter 55 CLA supplementation 55 Soy isoflavones 55 folate concentrations 55 glucose tolerance 55 C telopeptide 55 tHcy concentrations 55 bezafibrate 55 Apolipoprotein B 55 microvascular function 55 soy phytoestrogens 55 oral antidiabetes 55 intracranial hemorrhage ICH 55 continuous intravenous infusion 55 Humalog ® 55 aminotransferase 55 sedating antihistamine 55 sulphonylureas 55 pharmacodynamic PD 55 #ng/ml 55 ionized calcium 55 dietary modification 55 posttransplant 55 paraprotein 55 elevated triglycerides 55 lanthanum carbonate 55 lipid lowering agents 55 antioxidant supplementation 55 LDL cholesterol lowering 55 dose ritonavir 55 rimonabant #mg 55 arterial stiffening 55 oral prednisone 55 left ventricular diastolic 55 ginkgo biloba extract 55 lymphocyte counts 55 μg L 55 peripheral insulin sensitivity 55 AUC0 55 Endothelial function 55 mm Hg diastolic 55 dietary glycemic index 55 inecalcitol 55 elevated ALT 55 ALT elevations 55 transferrin saturation 55 fasting serum 55 estimated GFR 55 tolterodine ER 55 phenolic content 55 inhaled corticosteroids ICS 55 mEq L 55 serum lactate 55 fasting glucose 55 0mg 55 triglycerides TG 55 submaximal 55 atherogenic 55 plasma renin activity 55 hepatic glucose production 55 rosuvastatin #mg 55 abdominal adiposity 55 symptomatic GERD 55 complete cytogenetic response 55 fluticasone propionate FP 55 DAS# CRP 55 sodium benzoate preservative 55 bolus dose 55 systolic diastolic blood 55 Adequate vitamin D 55 oxygenated hemoglobin 55 salmeterol fluticasone propionate 55 diastolic blood pressures 55 Coenzyme Q 55 algal DHA 55 blood lipids 55 dietary DHA 55 GH deficiency 55 hyperresponsiveness 55 gastric emptying 55 lowers LDL cholesterol 55 abnormal glucose metabolism 55 dose Iluvien 55 cholesterol triglyceride 55 lumbar spine BMD 55 triglyceride levels 55 fat vegan diet 55 hypertensives 55 hs CRP 55 CVD mortality 55 angiotensin converting enzyme 55 oral antidiabetic drugs 55 primary aldosteronism 55 PaO 2 55 pg ml 55 gastric pH 55 polyphenol rich 55 calorie dieters 55 NSTE ACS 55 Adverse effects 55 #.#/#.# mm Hg [003] 55 hydroxyvitamin D levels 55 urate levels 55 QTc intervals 55 LV dysfunction 55 Stop Hypertension diet 55 baseline serum creatinine 55 arterial elasticity 55 amylin 55 BMI z 55 troponin T 55 cardiometabolic risk 55 glucose triglycerides 55 Epanova 55 hypercholesterolemic 55 receiving ISENTRESS 55 motilin 55 isoenzyme 55 intravascular volume 55 potassium sparing diuretics 55 phosphate binding 55 Ramipril 55 urinary protein 55 conduction velocity 55 hypericin 55 -#.# mg dL [001] 55 adjunctive placebo 55 #dhTxB# 55 tertile 55 serum testosterone 55 tipranavir r 55 pulmonary exacerbation 55 urate lowering 55 ACE inhibitor perindopril 55 macroalbuminuria 55 nondiabetic subjects 55 FFNS 55 HDL Cholesterol 55 inhaled budesonide 55 pCR 55 CIMZIA TM 55 CHD mortality 55 macrovascular events 55 vessel dilation 54 carotid plaque 54 haemodynamic 54 achieving PASI 54 linoleic acid LA 54 mg simvastatin 54 optimal glycemic 54 baseline LDH 54 ejection fractions 54 functional dyspepsia 54 carotid IMT 54 pravastatin Pravachol 54 β blocker 54 calculated creatinine clearance 54 serum PSA 54 insulin secretagogue 54 Lp PLA 2 54 dietary fiber intake 54 mucosal healing 54 serum albumin 54 steroid dexamethasone 54 vildagliptin 54 somatostatin analogs 54 thrombocytopenic 54 #IU [001] 54 Hematocrit 54 autoantibody levels 54 cystine 54 serum IgG 54 haematologic 54 polyp recurrence 54 pmol L 54 IDDM 54 serum sodium 54 pravastatin therapy 54 pulmonary exacerbations 54 hyperlipidaemia 54 NNT = 54 TMP SMX 54 dietary folate 54 prolactin levels 54 pulmonary artery pressure 54 UPDRS scores 54 Hypotension 54 glycated albumin 54 dietary calcium intake 54 verapamil 54 hypercholesterolaemia 54 eszopiclone 54 maximal aerobic 54 hydroxy vitamin D 54 pancreatic alpha 54 dose dependently 54 Riquent R abetimus 54 oral glucose tolerance 54 platelet inhibition 54 inflammatory markers 54 symptom exacerbation 54 milligrams deciliter 54 Sitagliptin 54 -#.# mmol L 54 bisoprolol 54 gm dL 54 cirrhotic patients 54 mL kg 54 calcium phosphorus 54 hypoglycemic events 54 echocardiographic parameters 54 hetastarch 54 creatine kinase CK 54 chlorthalidone 54 blood glucose 54 antigen PSA levels 54 Lovaza ® 54 dietary intakes 54 urinary calcium 54 fosamprenavir 54 glucose lowering 54 HpSA 54 antioxidative 54 ml kg 54 sargramostim 54 fat vegetarian diet 54 ritonavir boosted 54 creatine kinase MB 54 containing abacavir 54 nmol 54 Hb A1c 54 lymphocyte count 54 mg calcium 54 BENICAR 54 diuretic chlorthalidone 54 inducible nitric oxide synthase 54 intravascular hemolysis 54 per deciliter mg 54 NIHSS score 54 Thyroid hormone 54 urinary cortisol 54 arterial stiffness 54 anticoagulant warfarin 54 CrCl 54 unresectable HCC 54 cholestorol 54 parasitemia 54 gm dl 54 total cholesterol LDL 54 mg dl 54 corrected QT interval 54 lipoprotein profiles 54 thiazide diuretic 54 mmHg systolic 54 intestinal permeability 54 eicosapentaenoic acid 54 nitroprusside 54 foveal thickness 54 clomipramine 54 moderate aerobic exercise 54 intraocular pressure IOP 54 purine 54 β carotene 54 ug kg 54 co enzyme Q# 54 intima media thickness 54 potassium citrate 54 impaired endothelial 54 GHRH 54 binary restenosis 54 methacholine challenge 54 emphasizes fruits vegetables 54 Cardiorespiratory fitness 54 vasopressor 54 thyroid hormone levels 54 chewing sugarless gum 54 AGHD 54 elevated triglyceride levels 54 hyperlipidemic 54 Ceplene/IL-2 54 p = NS 54 HbA1c 54 pentoxifylline 54 Vitamin D supplementation 54 cardio respiratory fitness 54 lupus renal disease 54 central adiposity 54 bolus doses 54 x ULN 54 activated partial thromboplastin 54 nutrient density 54 pramlintide 54 thrombocytopenic patients 54 rizatriptan 54 DLQI 54 HIV HCV coinfected 54 blood phenylalanine Phe 54 SHBG levels 54 diabetic hypertensive 54 GLP1 54 Recommended Dietary Allowance 54 thyrotropin 54 lesional 54 arterial thickening 54 MS relapses 54 degludec 54 cerebral oxygenation 54 lipase units 54 electrical cardioversion 54 -#.# ± [001] 54 BARACLUDE ® 54 endoscopic remission 54 cranial irradiation 54 polyp detection 54 micromolar 54 ± SEM 54 elevated homocysteine 54 virological response 54 leptin deficient mice 54 GI toxicity 54 hypoglycemic episodes 54 elevated serum creatinine 54 remnant lipoproteins 54 oxycodone CR 54 Score DAS# 54 paclitaxel eluting stents 54 IFN beta 54 liver enzymes ALT 54 hyperglycaemic 54 B vitamin folate 54 Lucentis ranibizumab Genentech 54 benazepril 54 baseline A1C 54 plasma adiponectin 54 insulin sensitizing 54 nondiabetics 54 cardiac repolarization 54 plant sterol enriched 54 symptomatic VTE 54 metformin Glucophage 54 triiodothyronine 54 improving insulin sensitivity 54 APTIVUS r 54 MADRS score 54 receptor blockers 53 glucagon secretion 53 trough FEV1 53 serum BDNF 53 maximal aerobic capacity 53 serum bilirubin 53 #mg doses [002] 53 isoprostane 53 severe hypoglycemic 53 1c HbA 1c 53 treprostinil 53 XR NTX 53 LDL Cholesterol 53 Bone density 53 UACR 53 induced sputum 53 phosphorus binders 53 alkaline phosphatase 53 Glycemic Index GI 53 blood oxygen saturation 53 Zemplar Capsules 53 Gymnema 53 CCyR 53 exhaled nitric oxide 53 BMI percentiles 53 antiarrhythmic drug 53 metoprolol tartrate 53 hemoglobin Hb 53 skin sterol 53 tranylcypromine 53 severe hepatic insufficiency 53 dose proportionality 53 titrating 53 thermic effect 53 -#.# ± [002] 53 folic acid vitamin B# 53 impaired fasting glucose 53 erythrocyte sedimentation rate 53 mg QD 53 dosing cohort 53 endothelial function 53 SBM frequency 53 EtOH 53 HDL LDL ratio 53 dosage regimens 53 lactulose 53 OADs 53 conventional DMARDs 53 analgesic efficacy 53 analgesic medications 53 ALT AST 53 sodium nitroprusside 53 Homocysteine levels 53 #mg/kg [002] 53 apneic episodes 53 fluvastatin Lescol 53 severe hypoglycemia 53 baseline Hb 53 fruits vegetables cereals 53 glycemic 53 circulating lymphocytes 53 mg BID dose 53 nmol liter 53 prednisone prednisolone 53 estimated glomerular filtration 53 TPMT 53 octreotide LAR 53 oral FTY# 53 proliferative diabetic retinopathy 53 fibrinolysis 53 enterolactone 53 ketogenic 53 metabolite concentrations 53 mL/min/#.# m2 53 GERD symptom 53 p = .# [002] 53 cardiovascular morbidity 53 inotropes 53 ‰ ¥ 53 #.#mmol l [002] 53 kcals 53 ACTOplus met XR 53 tumor histology 53 p = #.# [003] 53 PYY 53 paraoxonase 53 inotropic agents 53 MMSE score 53 symptomatic intracranial hemorrhage 53 lipid lowering drugs 53 stimulant phentermine 53 Stop Hypertension DASH diet 53 infarct size 53 carotid artery intima media 53 CYT# QbG# 53 non starchy vegetables 53 metabolize sugars 53 ACEIs 53 ketogenic diets 53 secondary hyperparathyroidism 53 vitamin D2 53 microvascular complications 53 achieved statistical significance 53 ALT elevation 53 #ug [001] 53 hepatic function 53 serum potassium levels 53 hypertensive patients 53 chronic thromboembolic pulmonary 53 postprocedure 53 neutropenic 53 albumin protein 53 hemodilution 53 severe periodontitis 53 1mg dose 53 antihypertensive medications 53 intratumoral 53 urinary cadmium 53 serum clusterin levels 53 arteriolar 53 Riboflavin 53 biochemical relapse 53 flavonoid rich 53 postprandial hyperglycemia 53 phylloquinone 53 asymptomatic carotid stenosis 53 lipid elevations 53 mEq 53 CC genotype 53 nocturnal hypoglycemia 53 dose cohort 53 serum leptin 53 E selectin 53 rapid virological response 53 raw cruciferous vegetables 53 ApoA1 53 dose statin therapy 53 partial thromboplastin 53 DAS# scores 53 Secondary efficacy endpoints 53 fibrin deposition 53 elevated IOP 53 elevated TSH 53 GI motility 53 Qmax 53 residual platelet reactivity 53 abdominal circumference 53 divalproex sodium 53 Vigorous exercise 53 brachial blood 53 achieved ACR# 53 severe renal insufficiency 53 thromboxane A2